주의력결핍 과잉행동장애에서 오메가-3의 효과에 대한 고찰

• Published in: Soa--chʻŏngsonyŏn chŏngsin ŭihak = Journal of child & adolescent psychiatry Vol. 27; no. 1; pp. 31 - 38
• Main Authors: 박소영(So-Young Park), 이소영(Soyoung Irene Lee), 이문수(Moon-Soo Lee)
• Format: Journal Article
• Language: Korean
• Published: 대한소아청소년정신의학회 2016
• Subjects: ADHD; 주의력결핍 과잉행동장애; Omega-3; Polyunsaturated Fatty Acids; 불포화 지방산; 오메가-3; 3
• ISSN: 1225-729X; 2233-9183
• DOI: 10.5765/jkacap.2016.27.1.31

Pharmacotherapy is considered the first line therapy in attention-deficit hyperactivity disorder (ADHD). Many patients also choose complementary medicine such as dietary supplements. Omega-3 has shown some efficacy for improving ADHD symptoms in several studies. The goal of this review is to integrate the previous research findings on omega-3 and understand the issues worth considering in the treatment of ADHD. The terms "attention deficit disorder with hyperactivity", "omega-3", and "dietary supplements" were searched on PubMed, Cochrane, and Google scholar. The search was further limited to clinical trials, reviews, and meta-analyses. Trials that examined treatments for ADHD, used randomized design, and placebo-controlled trials were included. Eighteen clinical trials with a total of 1,141 participants were included in this review. Fifteen trials had parallel designs, comparing an omega-3/6 polyunsaturated fatty acid (PUFAs) or a combination of both to a placebo and three compared omega-3/6 PUFAs to a placebo and psycho-stimulants. Seven of the included trials showed significant improvements in groups receiving omega-3/6 PUFAs compared to placebo groups, however, 11 trials showed no significant differences. Evidence that PUFAs supplementation provides benefits for ADHD was yet limited. Mixed results were due to selection variability criteria, variability of supplementation, and short follow-up intervals.